Chestnut Hill, MA, United States of America

Rosana Kapeller-Libermann

This inventor holds 58 USPTO granted patents and 29 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Peptidomimetic Macrocycles (CPC class C12N). Top assignees: Millennium Pharmaceuticals Limited, Aileron Therapeutics, Inc., Nimbus Iris, Inc.. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosana Kapeller-Libermann. Retrieved from https://idiyas.com/inventor/rosana-kapeller-libermann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 58 (Patent Applications = 29)

% Patents Active = 34.5

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 2 (Patent Applications = 18)

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 225(Granted Patents)

Forward Citations (Not Self Cited) = 217(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

47 out of 855

Millennium Pharmaceuticals Limited

patents

4 out of 44

Aileron Therapeutics, Inc.

Millenium Pharmaceuticals, Inc.

patents

6. 1 out of 77

Bayer Healthcare Aktiengesellschaft

patents

7. 1 out of 1

Rome Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

Peptidomimetic Macrocycles

IRAK Inhibitors

Human Protein Kinases

Therapeutic Compounds

Human Acyltransferase

Ubiquitin Proteases

Nucleic Acid Sequences

Protein Kinase Family

Amino Peptidase

Transferase Family Members

Screening Methods

Disease Treatment

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187758 - Compounds and methods for treating disease (2025-01-07),

2. 10300109 - Peptidomimetic macrocycles (2019-05-28),

3. 9751892 - IRAK inhibitors and uses thereof (2017-09-05),

4. 9458202 - Peptidomimetic macrocycles with improved properties (2016-10-04),

5. 9212190 - IRAK inhibitors and uses thereof (2015-12-15),

6. 9175007 - IRAK inhibitors and uses thereof (2015-11-03),

7. 8808694 - Therapeutic peptidomimetic macrocycles (2014-08-19),

8. 8399405 - Peptidomimetic macrocycles (2013-03-19),

9. 8334111 - Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor (2012-12-18),

10. 7977059 - 17867, a novel human aminopeptidase (2011-07-12),

11. 7910346 - Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor (2011-03-22),

12. 7820403 - ACTR-1, a novel human acyltransferase and uses thereof (2010-10-26),

13. 7704711 - Human protein kinases and uses therefor (2010-04-27),

14. 7696316 - 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor (2010-04-13),

15. 7527962 - Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor (2009-05-05),

Title: The Innovative Journey of Rosana Kapeller-Libermann

Introduction: Rosana Kapeller-Libermann, a pioneering inventor based in Chestnut Hill, MA, has made significant contributions to the field of biotechnology with her groundbreaking innovations.

Latest Patents: Rosana Kapeller-Libermann's latest patents focus on novel therapies for autoimmune diseases, showcasing her commitment to developing cutting-edge solutions for complex medical conditions.

Career Highlights: With a background in molecular biology and a passion for translating scientific discoveries into tangible treatments, Rosana Kapeller-Libermann has led successful research teams and spearheaded projects that have the potential to revolutionize healthcare.

Collaborations: Throughout her career, Rosana Kapeller-Libermann has collaborated with leading research institutions, pharmaceutical companies, and academic experts to bring her inventions to life. Her collaborative spirit has been instrumental in driving forward progress in the biotechnology industry.

Conclusion: Rosana Kapeller-Libermann's dedication to innovation and her relentless pursuit of scientific excellence continue to inspire the next generation of inventors in the ever-evolving landscape of biotechnology.

Profile summary based on public USPTO records.